SHARED VALUE After negotiating an additional 18% price reduction, Morgan and Victoria decided to purchase from Schlechte Medizin GmbH. They view this as a long term strategic decision, as they also have plans to enter into the European market in the next year. An Interesting Phone Call Prior to Schlechte Medizin's first shipment, Lars Schoch, a representative from Schlechte Medizin, called Morgan. Lars stated that the first shipment will be leaving their facility in Germany in the next 3 days. All of the materials ordered are in good condition. However, there is concern that the ESV-2023 virus has spread into the Czech Republic. Lars stated that this could interrupt future shipments since their suppliers' workforce could be compromised by the virus. Lars said that Schlechte Medizin's Czech Republic suppliers have committed to produce all outstanding orders, but timing will likely be delayed. Schlechte Medizin has placed orders with their suppliers for 6 months of shipments. At the end of the call, Lars mentioned that it is unfortunate that the hospital system near the suppliers did not have the financial resources to purchase just one shipment of medical supplies that are being produced by Schlechte Medizin's suppliers. If the hospital system and supporting infrastructure had the correct medical supplies, likely the suppliers would be able to maintain their shipping schedule for the long term. Morgan thought about this conversation that night. The Eastern Europe region is a target market for CareMed's entry into Europe. Discuss how CareMed could structure a social responsibility program that could bring long term shared value to the Czech Republic and CareMed